CorVel (CRVL) Competitors $86.71 -1.89 (-2.13%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$86.68 -0.03 (-0.03%) As of 08/1/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRVL vs. DVA, CHE, AMED, MD, AMN, CCRN, LH, DGX, APG, and ULSShould you be buying CorVel stock or one of its competitors? The main competitors of CorVel include DaVita (DVA), Chemed (CHE), Amedisys (AMED), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Labcorp (LH), Quest Diagnostics (DGX), APi Group (APG), and UL Solutions (ULS). CorVel vs. Its Competitors DaVita Chemed Amedisys Pediatrix Medical Group AMN Healthcare Services Cross Country Healthcare Labcorp Quest Diagnostics APi Group UL Solutions CorVel (NASDAQ:CRVL) and DaVita (NYSE:DVA) are both health care services companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, media sentiment, institutional ownership, dividends, profitability and earnings. Which has more volatility & risk, CRVL or DVA? CorVel has a beta of 0.98, suggesting that its stock price is 2% less volatile than the S&P 500. Comparatively, DaVita has a beta of 1.09, suggesting that its stock price is 9% more volatile than the S&P 500. Which has preferable earnings and valuation, CRVL or DVA? DaVita has higher revenue and earnings than CorVel. DaVita is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCorVel$895.59M4.98$95.17M$1.8447.13DaVita$12.82B0.82$936.34M$10.0913.72 Do insiders and institutionals have more ownership in CRVL or DVA? 51.4% of CorVel shares are owned by institutional investors. Comparatively, 90.1% of DaVita shares are owned by institutional investors. 44.6% of CorVel shares are owned by company insiders. Comparatively, 2.0% of DaVita shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media favor CRVL or DVA? In the previous week, DaVita had 7 more articles in the media than CorVel. MarketBeat recorded 9 mentions for DaVita and 2 mentions for CorVel. DaVita's average media sentiment score of 1.29 beat CorVel's score of 0.75 indicating that DaVita is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CorVel 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DaVita 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer CRVL or DVA? DaVita has a consensus price target of $167.40, suggesting a potential upside of 20.92%. Given DaVita's stronger consensus rating and higher probable upside, analysts clearly believe DaVita is more favorable than CorVel.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CorVel 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00DaVita 1 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is CRVL or DVA more profitable? CorVel has a net margin of 10.63% compared to DaVita's net margin of 6.63%. DaVita's return on equity of 176.11% beat CorVel's return on equity.Company Net Margins Return on Equity Return on Assets CorVel10.63% 32.55% 18.22% DaVita 6.63%176.11%4.66% SummaryDaVita beats CorVel on 11 of the 16 factors compared between the two stocks. Get CorVel News Delivered to You Automatically Sign up to receive the latest news and ratings for CRVL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRVL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRVL vs. The Competition Export to ExcelMetricCorVelBUSINESS SVCS IndustryBusiness SectorNASDAQ ExchangeMarket Cap$4.56B$5.95B$14.77B$9.51BDividend YieldN/A3.12%2.81%4.09%P/E Ratio47.2124.4124.0523.80Price / Sales4.981.8368.4066.58Price / Cash36.4915.6526.9457.96Price / Book13.835.045.075.55Net Income$95.17M$155.75M$195.86M$259.03M7 Day Performance-2.29%-4.86%-4.24%-4.59%1 Month Performance-14.48%-1.42%-1.10%4.46%1 Year Performance-13.64%46.23%28.98%18.03% CorVel Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRVLCorVel1.0735 of 5 stars$86.71-2.1%N/A-15.2%$4.56B$895.59M47.215,075News CoverageUpcoming EarningsDVADaVita4.4495 of 5 stars$145.37+0.1%$167.40+15.2%+0.7%$10.96B$12.82B14.4176,000News CoveragePositive NewsUpcoming EarningsCHEChemed4.972 of 5 stars$464.55-1.3%$596.67+28.4%-29.0%$6.89B$2.43B22.6315,695Trending NewsEarnings ReportAnalyst ForecastAMEDAmedisys2.9262 of 5 stars$96.91-1.1%$100.67+3.9%+0.4%$3.21B$2.35B35.7619,000Trending NewsEarnings ReportAnalyst RevisionMDPediatrix Medical Group2.7225 of 5 stars$12.66+0.7%$16.67+31.6%+45.1%$1.08B$2.01B-12.534,305Positive NewsUpcoming EarningsAMNAMN Healthcare Services4.496 of 5 stars$19.71-0.5%$32.08+62.8%-73.3%$758.03M$2.98B-4.552,968Upcoming EarningsCCRNCross Country Healthcare3.5875 of 5 stars$13.81+1.5%$17.93+29.8%-25.7%$445.85M$1.34B-26.068,205News CoverageLHLabcorp4.8265 of 5 stars$261.15-1.4%$285.00+9.1%+12.0%$22.18B$13.01B28.8270,000Insider TradeDGXQuest Diagnostics4.9446 of 5 stars$167.84-0.4%$186.00+10.8%+15.7%$18.85B$9.87B20.1056,000Positive NewsAnalyst UpgradeInsider TradeAPGAPi Group3.3498 of 5 stars$34.74-1.2%$35.81+3.1%+45.5%$14.60B$7.14B113.2729,000Trending NewsEarnings ReportAnalyst RevisionULSUL Solutions2.5373 of 5 stars$70.09-0.3%$69.43-0.9%+40.0%$14.10B$2.87B41.9715,094News CoveragePositive NewsUpcoming EarningsShort Interest ↑ Related Companies and Tools Related Companies DVA Alternatives CHE Alternatives AMED Alternatives MD Alternatives AMN Alternatives CCRN Alternatives LH Alternatives DGX Alternatives APG Alternatives ULS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CRVL) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CorVel Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share CorVel With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
